Distinct mechanisms of the newborn innate immunity

Immunology Letters

Volumn 173, Issue , 2016, Pages 42-54

  Kumar, S Kingsley Manoj ^a   Bhat, B Vishnu ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Adaptive immunity; Immune response; Innate immunity; Microbiome; Newborns; Pro inflammatory cytokines

Indexed keywords

ACUTE PHASE PROTEIN; ADENOSINE; FIBRONECTIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MANNOSE BINDING LECTIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOGLOBULIN G;

ADAPTIVE IMMUNITY; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; DENDRITIC CELL; EPIGENETICS; GENETIC REGULATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MICROBIOME; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NEWBORN; NEWBORN PERIOD; NONHUMAN; PLASMA FACTOR; PRIORITY JOURNAL; REVIEW; ANIMAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PASSIVE IMMUNIZATION;

ADAPTIVE IMMUNITY; ANIMALS; ANIMALS, NEWBORN; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT, NEWBORN;

EID: 84961825270     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2016.03.009     Document Type: Review

References (198)

1. Lawn J.E., Cousens S., Zupan J. 4 million neonatal deaths: when? Where? Why?. Lancet (London, England) 2005, 365:891-900.
2. Vergnano S., Menson E., Kennea N., Embleton N., Russell A.B., Watts T., et al. Neonatal infections in England: the NeonIN surveillance network. Arch. Dis. Child. Fetal. Neonatal. Ed. 2011, 96:F9-F14.
3. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J. Endotoxin Res. 2005, 11:113-116.
4. Clapp W. Developmental regulation of the immune system. Semin. Perinatol. 2006, 30:69-72.
5. Siegrist C.A. Neonatal and early life vaccinology. Vaccine 2001, 19:3331-3346.
6. Adkins B. T-cell function in newborn mice and humans. Immunol. Today 1999, 20:330-335.
7. Salzman N.H. The role of the microbiome in immune cell development. Ann. Allergy Asthma Immunol. 2014, 113:593-598.
8. Gill S.R., Pop M., DeBoy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
9. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M., Hidalgo G., Fierer N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11971-11975.
10. Marcobal A., Sonnenburg J.L. Human milk oligosaccharide consumption by intestinal microbiota. Clin. Microbiol. Infect. 2012, 18:12-15. (s4).
11. Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell 2014, 157:121-141.
12. Marcobal A., Barboza M., Froehlich J.W., Block D.E., German J.B., Lebrilla C.B., et al. Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food Chem. 2010, 58:5334-5340.
13. Perez P.F., Doré J., Leclerc M., Levenez F., Benyacoub J., Serrant P., et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells?. Pediatrics 2007, 119:e724-32.
14. Elahi S., Ertelt J.M., Kinder J.M., Jiang T.T., Zhang X., Xin L., et al. Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature 2013, 504:158-162.
15. Olszak T., An D., Zeissig S., Vera M., Richter J., Franke A., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
16. An D., Oh S.F., Olszak T., Neves J.F., Avci F.Y., Erturk-Hasdemir D., et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 2014, 156:123-133.
17. Lotz M., Gütle D., Walther S., Ménard S., Bogdan C., Hornef M.W. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 2006, 203:973-984.
18. Deshmukh H.S., Liu Y., Menkiti O.R., Mei J., Dai N., O'Leary C.E., et al. The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice. Nat. Med. 2014, 20:524-530.
19. Karlsson H., Hessle C., Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 2002, 70:6688-6696.
20. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
21. Bouskra D., Brézillon C., Bérard M., Werts C., Varona R., Boneca I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
22. Rose S., Lichtenheld M., Foote M.R., Adkins B. Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J. Immunol. 2007, 178:2667-2678.
23. Schoenborn J.R., Dorschner M.O., Sekimata M., Santer D.M., Shnyreva M., Fitzpatrick D.R., et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat. Immunol. 2007, 8:732-742.
24. Webster R.B., Rodriguez Y., Klimecki W.T., Vercelli D. The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture. J. Biol. Chem. 2007, 282:700-709.
25. Martino D., Maksimovic J., Joo J.H., Prescott S.L., Saffery R. Genome-scale profiling reveals a subset of genes regulated by DNA methylation that program somatic T-cell phenotypes in humans. Genes Immun. 2012, 13:388-398.
26. Martino D.J., Tulic M.K., Gordon L., Hodder M., Richman T.R., Metcalfe J., et al. Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans. Epigenetics 2011, 6:1085-1094.
27. White G.P., Watt P.M., Holt B.J., Holt P.G. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J. Immunol. 2002, 168:2820-2827.
28. Jacoby M., Gohrbandt S., Clausse V., Brons N.H., Muller C.P. Interindividual variability and co-regulation of DNA methylation differ among blood cell populations. Epigenetics 2012, 7:1421-1434.
29. Luo C., Burgeon E., Carew J.A., McCaffrey P.G., Badalian T.M., Lane W.S., et al. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol. Cell. Biol. 1996, 16:3955-3966.
30. Chow C.W., Rincón M., Davis R.J. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell. Biol. 1999, 19:2300-2307.
31. Weitzel R.P., Lesniewski M.L., Haviernik P., Kadereit S., Leahy P., Greco N.J., et al. microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells. Blood 2009, 113:6648-6657.
32. Lederhuber H., Baer K., Altiok I., Sadeghi K., Herkner K.R., Kasper D.C. MicroRNA-146: tiny player in neonatal innate immunity?. Neonatology 2011, 99:51-56.
33. Nahid M.A., Satoh M., Chan E.K. Mechanistic role of microRNA-146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 2011, 186:1723-1734.
34. Adkins B. Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an immunodiverse developmental state. Immunol. Res. 2013, 57:246-257.
35. Wilson C.B., Lewis D.B. Basis and implications of selectively diminished cytokine production in neonatal susceptibility to infection. Rev. Infect. Dis. 1990, 12:S410-S420.
36. Wilson C.B., Westall J., Johnston L., Lewis D.B., Dower S.K., Alpert A.R. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J. Clin. Invest. 1986, 77:860-867.
37. Maródi L., Káposzta R., Campbell D.E., Polin R.A., Csongor J., Johnston R.B. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J. Immunol. 1994, 153:5643-5649.
38. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7:379-390.
39. Maródi L. Innate cellular immune responses in newborns. Clin. Immunol. 2006, 118:137-144.
40. Belderbos M.E., van Bleek G.M., Levy O., Blanken M.O., Houben M.L., Schuijff L., et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin. Immunol. 2009, 133:228-237.
41. Ndure J., Flanagan K.L. Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front. Microbiol. 2014, 5:477.
42. Andrade E.B., Alves J., Madureira P., Oliveira L., Ribeiro A., Cordeiro-da-Silva A., et al. TLR2-induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis. J. Immunol. 2013, 191:4759-4768.
43. Piccinni M.P., Giudizi M.G., Biagiotti R., Beloni L., Giannarini L., Sampognaro S., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 1995, 155:128-133.
44. Hilkens C.M., Vermeulen H., Neerven R., Snijdewint F.G., Wierenga E.A., Kapsenberg M.L. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin 2. Eur. J. Immunol. 1995, 25:59-63.
45. Vitoratos N., Papadias C., Economou E., Makrakis E., Panoulis C., Creatsas G. Elevated circulating IL-12 and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome. Mediators Inflamm. 2006, 2006:30485.
46. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH 2 phenomenon?. Immunol. Today 1993, 14:353-356.
47. Chelvarajan R.L., Collins S.M., Doubinskaia I.E., Goes S., Willigen J.V., Flanagan D., et al. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J. Leukoc. Biol. 2004, 75:982-994.
48. Pine L.T., Joyner J.L., Augustine N.H., Kwak S.D., Hill H.R. Defective production of IL-18 and IL-12 by cord blood mononuclear cells influences the T helper-1 interferon gamma response to group B Streptococci. Pediatr. Res. 2003, 54:276-281.
49. Vekemans J., Amedei A., Ota M.O., D'Elios M.M., Goetghebuer T., Ismaili J., et al. Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur. J. Immunol. 2001, 31:1531-1535.
50. Mascart F., Hainaut M., Peltier A., Verscheure V., Levy J., Locht C. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 2007, 25:391-398.
51. Nguyen M., Leuridan E., Zhang T., Wit D., Willems F., Damme P.V., et al. Acquisition of adult-Like TLR4 and TLR9 Responses during the first year of life. PLoS One 2010, 5:e10407.
52. Black A., Bhaumik S., Kirkman R.L., Weaver C.T., Randolph D.A. Developmental regulation of Th17-cell capacity in human neonates. Eur. J. Immunol. 2012, 42:311-319.
53. Corbett N.P., Blimkie D., Ho K.C., Cai B., Sutherland D.P., Kallos A., et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One 2010, 5:e15041.
54. Lavoie P.M., Huang Q., Jolette E., Whalen M., Nuyt A.M., Audibert F., et al. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. J. Infect. Dis. 2010, 202:1754-1763.
55. Kollmann T.R., Levy O., Montgomery R.R., Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012, 37:771-783.
56. Mackie R.I., Sghir A., Gaskins R.H. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 1999, 69:1035-1045.
57. Ogra P. Mucosal immune system in neonatal period and early infancy. Ped. Health 2010, 4:637-647.
58. Harris N.L., Spoerri I., Schopfer J.F., Nembrini C., Merky P., Massacand J., et al. Mechanisms of neonatal mucosal antibody protection. J. Immunol. 2006, 177:6256-6262.
59. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22:240-273.
60. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
61. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
62. Nupponen I., Kuuliala A., Siitonen S., Repo H., Kuuliala K. Cord blood monocytes, neutrophils and lymphocytes from preterm and full-term neonates show multiple aberrations in signalling profiles measured using phospho-specific whole-blood flow cytometry. Scand. J. Immunol. 2013, 78:426-438.
63. Christensen R.D., Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. Eur. J. Pediatr. 1980, 96:316-318.
64. Miller M.E. Phagocyte function in the neonate: selected aspects. Pediatrics 1979, 64:709-712.
65. Linderkamp O., Ruef P., Brenner B., Gulbins E., Lang F. Passive deformability of mature immature, and active neutrophils in healthy and septicemic neonates. Pediatr. Res. 1998, 44:946-950.
66. Maheshwari A. Neutropenia in the newborn. Curr. Opin. Hematol. 2014, 21:43-49.
67. Anderson D.C., Abbassi O., Kishimoto T.K., Koenig J.M., McIntire L.V., Smith C.W. Diminished lectin epidermal growth factor, complement binding domain-cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells in vitro. J. Immunol. 1991, 146:3372-3379.
68. Howard T.H., Meyer W.H. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J. Cell Biol. 1984, 98:1265-1271.
69. Türkmen M., Satar M., Atici A. Neutrophil chemotaxis and random migration in preterm and term infants with sepsis. Am. J. Perinatol. 2000, 17:107-112.
70. Zhu J., Zhang H., Guo T., Li W., Li H., Zhu Y., et al. Quantitative proteomics reveals differential biological processes in healthy neonatal cord neutrophils and adult neutrophils. Proteomics 2014, 14:1688-1697.
71. Birle A., Nebe C.T., Hill S., Hartmann K., Poeschl J., Koch L. Neutrophil chemotaxis in cord blood of term and preterm neonates is reduced in preterm neonates and influenced by the mode of delivery and anaesthesia. PLoS One 2015, 10:e0120341.
72. Nussbaum C., Gloning A., Pruenster M., Frommhold D., Bierschenk S., Genzel-Boroviczény O., et al. Neutrophil and endothelial adhesive function during human fetal ontogeny. J. Leukoc. Biol. 2013, 93:175-184.
73. Filias A., Theodorou G.L., Mouzopoulou S., Varvarigou A.A., Mantagos S., Karakantza M. Phagocytic ability of neutrophils and monocytes in neonates. BMC Pediatr. 2011, 11:29.
74. Levy O., Martin S., Eichenwald E., Ganz T., Valore E., Carroll S.F., et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 1999, 104:1327-1333.
75. Drossou V., Kanakoudi F., Tzimouli V., Sarafidis K., Taparkou A., Bougiouklis D., et al. Impact of prematurity, stress and sepsis on the neutrophil respiratory burst activity of neonates. Biol. Neonate 1997, 72:201-209.
76. Song C., Wang C., Huang L. Human neonatal neutrophils are resistant to apoptosis with lower caspase-3 activity. Tohoku J. Exp. Med. 2011, 225:59-63.
77. Yost C.C., Cody M.J., Harris E.S., Thornton N.L., McInturff A.M., Martinez M.L., et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood 2009, 113:6419-6427.
78. Marcos V., Nussbaum C., Vitkov L., Hector A., Wiedenbauer E.M., Roos D., et al. Delayed but functional neutrophil extracellular trap formation in neonates. Blood 2009, 114:4908-4911.
79. Melvan J.N., Bagby G.J., Welsh D.A., Nelson S., Zhang P. Neonatal sepsis and neutrophil insufficiencies. Int. Rev. Immunol. 2010, 29:315-348.
80. Al-Hertani W., Yan S.R., Byers D.M., Bortolussi R. Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide. Clin. Invest. Med. 2007, 30:E44-53.
81. Basha S., Surendran N., Pichichero M. Immune responses in neonates. Expert Rev. Clin. Immunol. 2014, 10:1171-1184.
82. Levy O., Coughlin M., Cronstein B.N., Roy R.M., Desai A., Wessels M.R. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 2006, 177:1956-1966.
83. Cohen N.D., Bourquin J.R., Bordin A.I., Kuskie K.R., Brake C.N., Weaver K.B., et al. Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals. PLoS One 2014, 9:e109865.
84. Thornton N.L., Cody M.J., Yost C.C. Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology 2012, 101:140-146.
85. Rieber N., Gille C., Köstlin N., Schäfer I., Spring B., Ost M., et al. Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin. Exp. Immunol. 2013, 174:45-52.
86. Schefold J.C., Porz L., Uebe B., Poehlmann H., von Haehling S., Jung A., et al. Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis. J. Perinat. Med. 2015, 43:609-618.
87. Christensen R.D., Jensen J., Maheshwari A., Henry E. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63 000 records in a multihospital health-care system. J. Perinatol. 2010, 30:540-545.
88. Marchant E.A., Kan B., Sharma A.A., van Zanten A., Kollmann T.R., Brant R., et al. Attenuated innate immune defenses in very premature neonates during the neonatal period. Pediatr. Res. 2015, 78:492-497.
89. Marodi L., Scorba S., Nagy B. Chemotactic and random movement of human newborn monocytes. Eur. J. Pediatr. 1980, 135:73-75.
90. Mahdi M., Maródi L. Monocytes in neonatal immunity. NeoReviews 2010, 11:e558-e565.
91. Török C., Lundahl J., Hed J., Lagercrantz H. Diversity in regulation of adhesion molecules (Mac-1 and l-selectin) in monocytes and neutrophils from neonates and adults. Arch. Dis. Child. 1993, 68:561-565.
92. Prosser A., Hibbert J., Strunk T., Kok C.H., Simmer K., Richmond P., et al. Phagocytosis of neonatal pathogens by peripheral blood neutrophils and monocytes from newborn preterm and term infants. Pediatr. Res. 2013, 74:503-510.
93. Yerkovich S.T., Wikström M.E., Suriyaarachchi D., Prescott S.L., Upham J.W., Holt P.G. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr. Res. 2007, 62:547-552.
94. Valero N., Mosquera J., Levy A., Añez G., Marcucci R., Alvarez-Mon M. Differential induction of cytokines by human neonatal, adult, and elderly monocyte/macrophages infected with dengue virus. Viral Immunol. 2014, 27:151-159.
95. Sharma A.A., Jen R., Kan B., Sharma A., Marchant E., Tang A., et al. Impaired NLRP3 inflammasome activity during fetal development regulates IL-1β production in human monocytes. Eur. J. Immunol. 2015, 45:238-249.
96. Li Y.P., Yu S.L., Huang Z.J., Huang J., Pan J., Feng X., et al. An impaired inflammatory cytokine response to gram-negative LPS in human neonates is associated with the defective TLR-mediated signaling pathway. J. Clin. Immunol. 2015, 35:218-226.
97. Yan S.R., Qing G., Byers D.M., Stadnyk A.W., Al-Hertani W., Bortolussi R. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect. Immun. 2004, 72:1223-1229.
98. Levy O., Zarember K.A., Roy R.M., Cywes C., Godowski P.J., Wessels M.R. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 2004, 173:4627-4634.
99. Philbin V.J., Dowling D.J., Gallington L.C., Cortés G., Tan Z., Suter E.E., et al. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. J. Allergy Clin. Immunol. 2012, 130(2012):195-204. (e9).
100. Huang H.C., Yu H.R., Huang L.T., Huang H.C., Chen R.F., Lin I.C., et al. miRNA-125b regulates TNF-α production in CD14+ neonatal monocytes via post-transcriptional regulation. J. Leukoc. Biol. 2012, 92:171-182.
101. Leiber A., Graf B., Spring B., Rudner J., Köstlin N., Orlikowsky T.W., et al. Neonatal monocytes express antiapoptotic pattern of Bcl-2 proteins and show diminished apoptosis upon infection with Escherichia coli. Pediatr. Res. 2014, 76:142-149.
102. Gille C., Dreschers S., Leiber A., Lepiorz F., Krusch M., Grosse-Opphoff J., et al. The CD95/CD95L pathway is involved in phagocytosis-induced cell death of monocytes and may account for sustained inflammation in neonates. Pediatr. Res. 2013, 73:402-408.
103. Lissner M.M., Thomas B.J., Wee K., Tong A.J., Kollmann T.R., Smale S.T. Age-related gene expression differences in monocytes from human neonates, young adults, and older adults. PLoS One 2015, 10:e0132061.
104. Winterberg T., Vieten G., Meier T., Yu Y., Busse M., Hennig C., et al. Distinct phenotypic features of neonatal murine macrophages. Eur. J. Immunol. 2015, 45:214-224.
105. Speer C.P., Gahr M., Wieland M., Eber S. Phagocytosis-associated functions in neonatal monocyte-derived macrophages. Pediatr. Res. 1988, 24:213-216.
106. Liao S.L., Yeh K.W., Lai S.H., Lee W.I., Huang J.L. Maturation of Toll-like receptor 1-4 responsiveness during early life. Early Hum. Dev. 2013, 89:473-478.
107. Kurkjian C., Hollifield M., Lines J.L., Rogosky A., Empey K.M., Qureshi M., et al. Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection. Infect. Immun. 2012, 80:2835-2846.
108. Kraft J.D., Horzempa J., Davis C., Jung J.Y., Peña M.M., Robinson C.M. Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses. Immunology 2013, 139:484-493.
109. Schneider Z., Jani P.K.K., Szikora B., Végh A., Kövesdi D., Iliás A., et al. Overexpression of Bovine FcRn in mice enhances T-dependent immune responses by amplifying T helper cell frequency and germinal center enlargement in the spleen. Front. Immunol. 2015, 6:357.
110. Liu X., Lu L., Yang Z., Palaniyandi S., Zeng R., Gao L.Y., et al. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J. Immunol. 2011, 186:4674-4686.
111. Maródi L., Goda K., Palicz A., Szabó G. Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-γ. Clin. Exp. Immunol. 2001, 126:456-460.
112. Empey K.M., Orend J.G., Peebles R.S., Egaña L., Norris K.A., Oury T.D., et al. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PLoS One 2012, 7:e40499.
113. Saeed S., Quintin J., Kerstens H.H., Rao N.A., Aghajanirefah A., Matarese F., et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 2014, 345:1251086.
114. Hochrein H., O'Keeffe M. Dendritic cell subsets and toll-like receptors. Handb. Exp. Pharmacol. 2008, 183:153-179.
115. Willems F., Vollstedt S., Suter M. Phenotype and function of neonatal DC. Eur. J. Immunol. 2009, 39:26-35.
116. Wu L., Liu Y.J. Development of dendritic-cell lineages. Immunity 2007, 26:741-750.
117. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 2006, 7:663-671.
118. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
119. Borràs F.E., Matthews N.C., Lowdell M.W., Navarrete C.V. Identification of both myeloid CD11c+ and lymphoid CD11c- dendritic cell subsets in cord blood. Br. J. Haematol. 2001, 113:925-931.
120. Dakic A., Shao Q.X., D'Amico A., O'Keeffe M., Chen W.F., Shortman K., et al. Development of the dendritic cell system during mouse ontogeny. J. Immunol. 2004, 172:1018-1027.
121. Kollmann T.R., Crabtree J., Rein-Weston A., Blimkie D., Thommai F., Wang X.Y., et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 2009, 183:7150-7160.
122. Encabo A., Solves P., Carbonell-Uberos F., Miñana M.D. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation. Transfusion 2007, 47:272-279.
123. Hunt D.W., Huppertz H.I., Jiang H.J., Petty R.E. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 1994, 84:4333-4343.
124. De Wit D., Olislagers V., Goriely S., Vermeulen F., Wagner H., Goldman M., et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004, 103:1030-1032.
125. De Wit D., Tonon S., Olislagers V., Goriely S., Boutriaux M., Goldman M., et al. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J. Autoimmun. 2003, 21:277-281.
126. Danis B., George T.C., Goriely S., Dutta B., Renneson J., Gatto L., et al. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur. J. Immunol. 2008, 38:507-517.
127. Levy O., Suter E.E., Miller R.L., Wessels M.R. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 2006, 108:1284-1290.
128. Dadaglio G., Sun C.M., Lo-Man R., Siegrist C., Leclerc C. Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cells. J. Immunol. 2002, 168:2219-2224.
129. Salio M., Dulphy N., Renneson J., Herbert M., McMichael A., Marchant A., et al. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. Int. Immunol. 2003, 15:1265-1273.
130. Vollstedt S., O'Keeffe M., Odermatt B., Beat R., Glanzmann B., Riesen M., et al. Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-α production. Eur. J. Immunol. 2004, 34:1849-1860.
131. Lee H.H., Hoeman C.M., Hardaway J.C., Guloglu F.B., Ellis J.S., Jain R., et al. Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J. Exp. Med. 2008, 205:2269-2280.
132. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005, 434:243-249.
133. Goriely S., Molle C., Nguyen M., Albarani V., Haddou N.O., Lin R., et al. Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006, 107:1078-1084.
134. Langrish C.L., Buddle J.C., Thrasher A.J., Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin. Exp. Immunol. 2002, 128:118-123.
135. Goriely S., Vincart B., Stordeur P., Vekemans J., Willems F., Goldman M., et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 2001, 166:2141-2146.
136. Tonon S., Goriely S., Aksoy E., Pradier O., Del Giudice G., Trannoy E., et al. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur. J. Immunol. 2002, 32:3118-3125.
137. Goriely S., Van Lint C., Dadkhah R., Libin M., De Wit D., Demonté D., et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J. Exp. Med. 2004, 199:1011-1016.
138. Upham J.W., Lee P.T., Holt B.J., Heaton T., Prescott S.L., Sharp M.J., et al. Development of interleukin-12-producing capacity throughout childhood. Infect. Immun. 2002, 70:6583-6588.
139. Krumbiegel D., Zepp F., Meyer C.U. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum. Immunol. 2007, 68:813-822.
140. Nohmi K., Tokuhara D., Tachibana D., Saito M., Sakashita Y., Nakano A., et al. Zymosan induces immune responses comparable with those of adults in monocytes, dendritic cells, and monocyte-derived dendritic cells from cord blood. J. Pediatr. 2015, 167:155-162. (e1-2).
141. Aksoy E., Albarani V., Nguyen M., Laes J.F., Ruelle J.L., De Wit D., et al. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007, 109:2887-2893.
142. Drohan L., Harding J.J., Holm B., Cordoba-Tongson E., Dekker C.L., Holmes T., et al. Selective developmental defects of cord blood antigen-presenting cell subsets. Hum. Immunol. 2004, 65:1356-1369.
143. Guilmot A., Hermann E., Braud V.M.M., Carlier Y., Truyens C. Natural killer cell responses to infections in early life. J. Innate Immun. 2011, 3:280-288.
144. Pérez A., Gurbindo M.D., Resino S., Aguarón A., Muñoz-Fernández M.A. NK cell increase in neonates from the preterm to the full-term period of gestation. Neonatology 2007, 92:158-163.
145. de Vries E., de Bruin-Versteeg S., Comans-Bitter W.M., de Groot R., Hop W.C., Boerma G.J., et al. Neonatal blood lymphocyte subpopulations: a different perspective when using absolute counts. Biol. Neonate 2000, 77:230-235.
146. Garff-Tavernier M.L., Béziat V., Decocq J., Siguret V., Gandjbakhch F., Pautas E., et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010, 9:527-535.
147. Newman K.C., Riley E.M. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 2007, 7:279-291.
148. Bihl F., Pecheur J., Bréart B., Poupon G., Cazareth J., Julia V. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 2010, 185:2174-2181.
149. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
150. Krampera M., Tavecchia L., Benedetti F., Nadali G., Pizzolo G. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes. Haematologica 2000, 85:675-679.
151. Lau A.S., Sigaroudinia M., Yeung M.C., Kohl S. Interleukin-12 induces interferon-gamma expression and natural killer cytotoxicity in cord blood mononuclear cells. Pediatr. Res. 1996, 39:150-155.
152. Sundström Y., Nilsson C., Lilja G., Kärre K., Blomberg M., Berg L. The expression of human natural killer cell receptors in early life. Scand. J. Immunol. 2007, 66:335-344.
153. Braud V.M., Allan D.S., O'Callaghan C.A., Söderström K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998, 391:795-799.
154. Wang Y., Xu H., Zheng X., Wei H., Sun R., Tian Z. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell. Mol. Immunol. 2007, 4:377-382.
155. Dalle J.H., Menezes J., Wagner É., Blagdon M., Champagne J., Champagne M.A., et al. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr. Res. 2005, 57:649-655.
156. Wang Y., Xu H., Zheng X., Wei H., Sun R., Tian Z. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell. Mol. Immunol. 2007, 4:377-382.
157. Lin S.J., Cheng P.J., Lin T.Y., Lee P.T., Hsiao H.S., Kuo M.L. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15. J. Infect. Dis. 2012, 205:745-756.
158. Tanaka H., Kai S., Yamaguchi M., Misawa M., Fujimori Y., Yamamoto M., et al. Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur. J. Haematol. 2003, 71:29-38.
159. Kohl S., Sigouroudinia M., Engleman E.G. Adhesion defects of antibody-mediated target cell binding of neonatal natural killer cells. Pediatr. Res. 1999, 46:755-759.
160. Sivori S., Pende D., Bottino C., Marcenaro E., Pessino A., Biassoni R., et al. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 1999, 29:1656-1666.
161. Nguyen Q.H., Roberts R.L., Ank B.J., Lin S.J., Thomas E.K., Stiehm E.R. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell. Immunol. 1998, 185:83-92.
162. Bonnema J.D., Rivlin K.A., Ting A.T., Schoon R.A., Abraham R.T., Leibson P.J. Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J. Immunol. 1994, 152:2098-2104.
163. Webb B.J., Bochan M.R., Montel A., Padilla L.M., Brahmi Z. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell. Immunol. 1994, 159:246-261.
164. Slavica L., Nordström I., Karlsson M.N., Valadi H., Kacerovsky M., Jacobsson B. TLR3 impairment in human newborns. J. Leukoc. Biol. 2013, 94:1003-1011.
165. Hayward A., Laszlo M., Vafai A. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus. J. Immunol. 1989, 142:1139-1143.
166. Bernstein H.B., Kinter A.L., Jackson R., Fauci A.S. Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res. Hum. Retroviruses 2004, 20:1189-1195.
167. Nomura A., Takada H., Jin C.H., Tanaka T., Ohga S., Hara T. Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response. Exp. Hematol. 2001, 29:1169-1176.
168. Joshi P.C., Zhou X., Cuchens M., Jones Q. Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. J. Immunol. 2001, 166:885-891.
169. Trzonkowski P., Szmit E., Myśliwska J., Dobyszuk A., Myśliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin. Immunol. 2004, 112:258-267.
170. Ivarsson M.A., Loh L., Marquardt N., Kekäläinen E., Berglin L., Björkström N.K., et al. Differentiation and functional regulation of human fetal NK cells. J. Clin. Invest. 2013, 123:3889-3901.
171. McGreal E.P., Hearne K., Spiller O.B. Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth. Immunobiology 2012, 217:176-186.
172. Wolach B., Dolfin B.T., Regev R., Gilboa S., Schlesinger M. The development of the complement system after 28 weeks' gestation. Acta. Paediatr. 1997, 86:523-527.
173. Drew J.H., Arroyave C.M. The complement system of the newborn infant. Biol. Neonate 1980, 37:209-217.
174. Belderbos M.E., Levy O., Meyaard L., Bont L. Plasma-mediated immune suppression: a neonatal perspective. Pediatr. Allergy Immunol. 2013, 24:102-113.
175. Belderbos M.E., Levy O., Stalpers F., Kimpen J.L., Meyaard L., Bont L. Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors. PLoS One 2012, 7:e33419.
176. Petersen S.V., Thiel S., Jensenius J.C. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 2001, 38:133-149.
177. Jack D.L., Klein N.J., Turner M.W. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol. Rev. 2001, 180:86-99.
178. Sallenbach S., Thiel S., Aebi C., Otth M., Bigler S., Jensenius J.C., et al. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr. Allergy Immunol. 2011, 22:424-430.
179. Swierzko A., Cedzynski M., Domzalska-Popadiuk I., MacDonald S.L., Borkowska-Klos M., Atkinson A.P., et al. Mannan-binding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations. Mol. Immunol. 2009, 46:1696-1701.
180. Cedzynski M., Swierzko A.S., Kilpatrick D.C. Factors of the lectin pathway of complement activation and their clinical associations in neonates. J. Biomed. Biotechnol. 2012, 2012:363246.
181. Benedetti F., Auriti C., D'Urbano L.E., Ronchetti M., Ravà L., Tozzi A., et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr. Res. 2007, 61:325-328.
182. Frakking F.N.J., Brouwer N., van Eijkelenburg N.K.A., Merkus M.P., Kuijpers T.W., Offringa M., et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin. Exp. Immunol. 2007, 150:255-262.
183. Dzwonek A.B., Neth O.W., Thiébaut R., Gulczynska E., Chilton M., Hellwig T. The role of mannose-binding lectin in susceptibility to infection in preterm neonates. Pediatr. Res. 2008, 63:680-685.
184. Koçak U., Ezer U., Vidinlisan S. Serum fibronectin in neonatal sepsis: is it valuable in early diagnosis and outcome prediction?. Acta Paediatr. Jpn. 1997, 39:428-432.
185. Romeo M.G., Tina L.G., Sciacca A., Betta P., D'Amico P., Saporito A., et al. [Decreased plasma fibronectin (pFN) level in preterm infants with infections]. Pediatr Med. Chir. 1995, 17:563-566.
186. Polin R.A. Role of fibronectin in diseases of newborn infants and children. Rev. Infect. Dis. 1990, 12(Suppl. 4):S428-38.
187. Gerdes J.S., Yoder M.C., Douglas S.D., Polin R.A. Decreased plasma fibronectin in neonatal sepsis. Pediatrics 1984, 72:877-881.
188. Haskó G., Kuhel D.G., Chen J.F., Schwarzschild M.A., Deitch E.A., Mabley J.G., et al. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 2000, 14:2065-2074.
189. Karmouty-Quintana H., Philip K., Acero L.F., Chen N.Y., Weng T., Molina J.G., et al. Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension. FASEB J. 2015, 29:50-60.
190. Hou P.C., Yu H.R., Kuo H.C., Wang L., Lin L.Y., Sheen J.M., et al. Different modulating effects of adenosine on neonatal and adult polymorphonuclear leukocytes. Sci. World J. 2012, 2012. (Article ID 387923).
191. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990, 265:621-636.
192. Firth M., Shewen P., Hodgins D. Passive and active components of neonatal innate immune defenses. Anim. Health Res. Rev. 2005, 6:143-158.
193. Eklund K.K., Niemi K., Kovanen P.T. Immune functions of serum amyloid A. Crit. Rev. Immunol. 2012, 32:335-348.
194. Gardner R.M., Dalman C., Wicks S., Lee B.K., Karlsson H. Neonatal levels of acute phase proteins and later risk of non-affective psychosis. Transl. Psychiatry 2013, 3:e228.
195. Trend S., Strunk T., Hibbert J., Kok C., Zhang G., Doherty D., et al. Antimicrobial protein and peptide concentrations and activity in human breast milk consumed by preterm infants at risk of late-onset neonatal sepsis. PLoS One 2015, 10:e0117038.
196. Strunk T., Doherty D., Richmond P., Simmer K., Charles A., Levy O., et al. Reduced levels of antimicrobial proteins and peptides in human cord blood plasma. Arch. Dis. Child. Fetal Neonatal. Ed. 2009, 94:F230-F231.
197. Gantt S., Gervassi A., Jaspan H., Horton H. The role of myeloid-derived suppressor cells in immune ontogeny. Front. Immunol. 2014, 5:387.
198. Fong O.N., Chan K.Y., Leung K.T., Lam H.S., Cheung H.M., Leung T.Y., et al. Expression profile of cord blood neutrophils and dysregulation of HSPA1A and OLR1 upon challenge by bacterial peptidoglycan. J. Leukoc. Biol. 2014, 95:169-178.